Citation Impact
Citing Papers
Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women
2007
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Degradation of proteins by PROTACs and other strategies
2019
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
2014 Standout
Glucocorticoid receptor activation in the rat nucleus of the solitary tract facilitates memory consolidation: involvement of the basolateral amygdala
1999
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
1999 Standout
Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands
2006
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Steroid Hormones, Receptors, and Antagonists
1996
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
2008
Bicalutamide (Casodex®) in the treatment of prostate cancer
2004
Autophagy as a cell death and tumor suppressor mechanism
2004 Standout
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants
2021 Standout
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
In vitro and in vivo biologic evaluation of long‐circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668
2003
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
The development of androgen-independent prostate cancer
2001 Standout
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
Pharmacodynamics of Selective Androgen Receptor Modulators
2003
Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
2000
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Estrogenic endocrine disruptors: Molecular mechanisms of action
2015
Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase
1995
Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms
2014
Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties
2003
Fluorogenic and fluorescent labeling reagents with a benzofurazan skeleton
2001
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
2004 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
2018
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Contraceptive Technology
2021 Standout
Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
2010
Potential targets in the discovery of new hair growth promoters for androgenic alopecia
2014
A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification
2017 Standout
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Autophagy in cell death: an innocent convict?
2005 Standout
A dithienylethene-tethered β-cyclodextrin dimer as a photoswitchable host
2002 StandoutNobel
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy
1996
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
1998 Standout
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
Induced protein degradation: an emerging drug discovery paradigm
2016
Pharmacology, Pharmacokinetics, and Metabolism of Acetothiolutamide, a Novel Nonsteroidal Agonist for the Androgen Receptor
2003
Recent developments in the synthesis of 11β-aryl-estrone derivatives
2003
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Estrogen Receptors as Therapeutic Targets in Breast Cancer
2008
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Physicochemical Characteristics and Preliminary in Vivo Biological Evaluation of Nanocapsules Loaded with siRNA Targeting Estrogen Receptor Alpha
2008
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
2005 Standout
Organometallic Anticancer Compounds
2010 Standout
Anti‐Estrogen‐Loaded Superparamagnetic Liposomes for Intracellular Magnetic Targeting and Treatment of Breast Cancer Tumors
2010
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Basic Guide to the Mechanisms of Antiestrogen Action
1998
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Various Phosphorylation Pathways, Depending on Agonist and Antagonist Binding to Endogenous Estrogen Receptor α (ERα), Differentially Affect ERα Extractability, Proteasome-Mediated Stability, and Transcriptional Activity in Human Breast Cancer Cells
2003
Alternative Splicing of the D2Dopamine Receptor Messenger Ribonucleic Acid Is Modulated by Activated Sex Steroid Receptors in the MMQ Prolactin Cell Line1
1998
Porphyrin-based photosensitizers for use in photodynamic therapy
1998
Facile route to ferrocifen, 1-[4-(2-dimethylaminoethoxy)]-1-(phenyl-2-ferrocenyl-but-1-ene), first organometallic analogue of tamoxifen, by the McMurry reaction
1997
Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis
2015
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Antimicrobial Arylcoumarins from Asphodelus microcarpus
2007
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
BODIPY dyes in photodynamic therapy
2012 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Synthesis and structure–activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands
2001
THE AMYGDALA MODULATES THE CONSOLIDATION OF MEMORIES OF EMOTIONALLY AROUSING EXPERIENCES
2004 Standout
Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
2008
Redox‐ and pH‐Controlled Mechanized Nanoparticles
2009 StandoutNobel
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Works of F. Bouchoux being referenced
Synthesis and relative binding affinity to human steroid receptors of substituted 3-aryloxycoumarins
2003
The pharmacological profile of a novel norpregnane progestin (trimegestone)
1999
Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders
1998
RU 58 668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice
1994
Non-steroidal antiandrogens: Synthesis and biological profile of high-affinity ligands for the androgen receptor
1994
General Structure‐Activity Correlations of Antihormones
1995
Synthesis and binding affinity to human α and β estrogen receptors of various 7-hydroxycoumarins substituted at 4- and 3,4- positions
2004
Synthesis of a fluorescent steroid derivative with high affinities for the glucocorticoid and progesterone receptors
1994
Synthesis and Relative Binding Affinity to Human Steroid Receptors of Substituted 3‐Aryloxycoumarins.
2004
[Synthesis and binding affinity of 3-aryl-7-hydroxycoumarins to human alpha and beta estrogen receptors].
2003
[Binding affinity to steroid hormone receptors and antiproliferative action on MCF-7 cells of coumarin derivatives and isoflavonoids].
1999